Exact Mass: 528.2207

16,17-Dihydro-16alpha,17-dihydroxygibberellin A4 17-glucoside

C25H36O12 (528.2207)

16,17-Dihydro-16alpha,17-dihydroxygibberellin A4 17-glucoside belongs to the class of organic compounds known as diterpene glycosides. These are diterpenoids in which an isoprene unit is glycosylated. 16,17-Dihydro-16alpha,17-dihydroxygibberellin A4 17-glucoside is found in cereals and cereal products. 16,17-Dihydro-16alpha,17-dihydroxygibberellin A4 17-glucoside is a constituent of rice (Oryza sativa) flower anthers. Constituent of rice (Oryza sativa) flower anthers. 16,17-Dihydro-16a,17-dihydroxygibberellin A4 17-glucoside is found in cereals and cereal products.

Dutasteride

C27H30F6N2O2 (528.2211)

Dutasteride belongs to a class of drugs called 5-alpha-reductase inhibitors, which block the action of the 5-alpha-reductase enzymes that convert testosterone into dihydrotestosterone (DHT). Finasteride also belongs to this group, but while dutasteride inhibits both isoforms of 5-alpha reductase, finasteride inhibits only one. Even so, a clinical study done by GlaxoSmithKline, the EPICS trial, did not find dutasteride to be more effective than finasteride in treating BPH. [Wikipedia] G - Genito urinary system and sex hormones > G04 - Urologicals > G04C - Drugs used in benign prostatic hypertrophy > G04CB - Testosterone-5-alpha reductase inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058891 - 5-alpha Reductase Inhibitors C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C2319 - 5 Alpha-Reductase Inhibitor C1892 - Chemopreventive Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Kickxioside

C25H36O12 (528.2207)

Abelioside B

C25H36O12 (528.2207)

Salvinicin B

C25H36O12 (528.2207)

6-O-nerol-8-oyl-antirrinoside

C25H36O12 (528.2207)

Sarcaglaboside D

C25H36O12 (528.2207)

nemoroside I

C25H36O12 (528.2207)

Dutasteride

C27H30F6N2O2 (528.2211)

G - Genito urinary system and sex hormones > G04 - Urologicals > G04C - Drugs used in benign prostatic hypertrophy > G04CB - Testosterone-5-alpha reductase inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058891 - 5-alpha Reductase Inhibitors C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C2319 - 5 Alpha-Reductase Inhibitor C1892 - Chemopreventive Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

C25H36O12_2,7-Octadienoic acid, 6-hydroxy-2,6-dimethyl-, (1aR,1bS,2S,5aS,6R,6aS)-2-(beta-D-glucopyranosyloxy)-1a,1b,2,5a,6,6a-hexahydro-5a-hydroxy-1a-methyloxireno[4,5]cyclopenta[1,2-c]pyran-6-yl ester, (2E,6S)

C25H36O12 (528.2207)

[(1aR,1bS,2S,5aS,6R,6aS)-5a-hydroxy-1a-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1b,2,6,6a-tetrahydrooxireno[1,2]cyclopenta[4,5-b]pyran-6-yl] (2E,6S)-6-hydroxy-2,6-dimethylocta-2,7-dienoate

C25H36O12 (528.2207)

[(1aR,1bS,2S,5aS,6R,6aS)-5a-hydroxy-1a-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1b,2,6,6a-tetrahydrooxireno[1,2]cyclopenta[4,5-b]pyran-6-yl] (2E,6S)-6-hydroxy-2,6-dimethylocta-2,7-dienoate_major

C25H36O12 (528.2207)

[(1aR,1bS,2S,5aS,6R,6aS)-5a-hydroxy-1a-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1b,2,6,6a-tetrahydrooxireno[1,2]cyclopenta[4,5-b]pyran-6-yl] (2E,6S)-6-hydroxy-2,6-dimethylocta-2,7-dienoate_35.8\\%

C25H36O12 (528.2207)

16,17-Dihydro-16a,17-dihydroxygibberellin A4 17-glucoside

C25H36O12 (528.2207)

5β-Dutasteride

C27H30F6N2O2 (528.2211)

(1R,3aS,3bS,5aR,9aR,9bR,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide

C27H30F6N2O2 (528.2211)

16,17-Dihydro-16alpha,17-dihydroxygibberellin A4 17-glucoside

C25H36O12 (528.2207)

ST 19:2;O6;GlcA

C25H36O12 (528.2207)

ST 19:3;O7;Hex

C25H36O12 (528.2207)

6-hydroxy-2-methyl-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl 6-hydroxy-2,6-dimethylocta-2,7-dienoate

C25H36O12 (528.2207)

(4ar,6s,7r,7as)-7-methyl-3-oxo-hexahydro-1h-cyclopenta[c]pyran-6-yl (4s,5s,6s)-5-ethenyl-4-(2-hydroxyethyl)-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

C25H36O12 (528.2207)

6-hydroxy-2-methyl-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl 8-hydroxy-2,6-dimethylocta-2,6-dienoate

C25H36O12 (528.2207)

(4ar,6s,7r,7as)-7-methyl-3-oxo-hexahydro-1h-cyclopenta[c]pyran-6-yl (4s,5r,6s)-5-ethenyl-4-(2-hydroxyethyl)-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

C25H36O12 (528.2207)

methyl 9-(acetyloxy)-2-(3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl)-6a,10b-dimethyl-4,10-dioxo-octahydro-1h-naphtho[2,1-c]pyran-7-carboxylate

C25H36O12 (528.2207)

methyl (2s,4ar,6ar,7r,9s,10as,10br)-9-(acetyloxy)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl]-6a,10b-dimethyl-4,10-dioxo-octahydro-1h-naphtho[2,1-c]pyran-7-carboxylate

C25H36O12 (528.2207)

methyl (2s,4ar,6ar,7r,9s,10as,10br)-9-(acetyloxy)-2-[(2r,3s,4s,5s)-3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl]-6a,10b-dimethyl-4,10-dioxo-octahydro-1h-naphtho[2,1-c]pyran-7-carboxylate

C25H36O12 (528.2207)

(1s,2r,4s,5r,6r,10s)-6-hydroxy-2-methyl-10-{[(2s,3s,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl (2e,6s)-6-hydroxy-2,6-dimethylocta-2,7-dienoate

C25H36O12 (528.2207)

(1s,2s,4s,5s,6r,10s)-2-(hydroxymethyl)-10-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl (2e,6e)-8-hydroxy-2,6-dimethylocta-2,6-dienoate

C25H36O12 (528.2207)

(1r,2s,4r,5s,6r,10r)-6-hydroxy-2-methyl-10-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl (2e,6r)-6-hydroxy-2,6-dimethylocta-2,7-dienoate

C25H36O12 (528.2207)

7-methyl-3-oxo-hexahydro-1h-cyclopenta[c]pyran-6-yl 5-ethenyl-4-(2-hydroxyethyl)-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

C25H36O12 (528.2207)

(4ar,6s,7r,7ar)-7-methyl-3-oxo-hexahydro-1h-cyclopenta[c]pyran-6-yl (4s,5r,6r)-5-ethenyl-4-(2-hydroxyethyl)-6-{[(2s,3s,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

C25H36O12 (528.2207)

(1s,2r,4s,5r,6s,10s)-6-hydroxy-2-methyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl (2e,6z)-8-hydroxy-2,6-dimethylocta-2,6-dienoate

C25H36O12 (528.2207)

(1s,2r,4s,5r,6s,10s)-6-hydroxy-2-methyl-10-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl (2e,6s)-6-hydroxy-2,6-dimethylocta-2,7-dienoate

C25H36O12 (528.2207)

2-(hydroxymethyl)-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl (2e)-6-hydroxy-2,6-dimethylocta-2,7-dienoate

C25H36O12 (528.2207)